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Abstract.  The microfibrillar glycoprotein fibrillin is 
linked to the Marfan syndrome, an autosomal domi- 
nant connective tissue disorder.  In this study, fibrillin 
synthesis, deposition and assembly has been inves- 
tigated in Marfan dermal fibroblast lines from two un- 
related patients for whom distinct mutations in the 
fibrillin gene FBN1 have been identified. In patient 
NB, a point mutation has occurred which causes an 
amino acid substitution and the other patient (GK) has 
a deletion in one allele. 
The two cell lines were broadly comparable with re- 
spect to de novo fibrillin synthesis and its distribution 
between medium and cell layer compartments.  Elec- 
trophoresis of tibriUin immunoprecipitates confirmed 
the presence of fibrillin in medium and cell layers. GK 
cells secreted an additional higher relative molecular 
mass fibriUin-immunoreactive component.  The time- 
course of fibrillin secretion was similar for the two 
lines, but differences in fibrillin aggregation were ap- 
parent. 
Rotary shadowing electron microscopy of extracted 
cell layers demonstrated the presence of abundant and 
extensive microfibrils in NB cell layers.  These were 
abnormal in their gross morphology in comparison to 
microfibrils isolated from control cultures.  No periodic 
microfibrillar structures were isolated from GK cell 
layers. 
These studies underline the need to classify fibrillin 
defects in terms of biochemical and ultrastructural 
criteria.  Examination of the effects of individual muta- 
tions on microfibril organization will be particularly 
informative in elucidating the relationship between 
microfibril dysfunction and the complex clinical 
manifestations of Marfan patients. 
I 
T is now well established that mutations in the fibrillin 
gene (FBN1) on chromosome 15 are the primary lesions 
in the heritable connective tissue disorder,  Marfan syn- 
drome, which is characterized by cardiovascular,  skeletal, 
and  ocular  abnormalities  (Dietz  et  al.,  1991, 1992a,b; 
1993a,b; Kainulainen  et al.,  1991, 1992,  1993; Lee et al., 
1991; Godfrey et al., 1993; Hewitt et ai., 1993). The glyco- 
protein fibrillin is a major structural  component of a distinct 
class of extracellular  matrix microfibrils  which are key de- 
terminants  of connective tissue architecture  and  integrity 
(Sakai  et ai.,  1986, 1991). The fibrillin-containing  micro- 
fibrils have a widespread tissue distribution  and are particu- 
larly abundant in elastic tissues such as aorta, ligament,  and 
skin where they are components of elastic fibers which gen- 
erate elastic recoil (Cleary and Gibson,  1983).  Ultrastruc- 
turaUy  indistinguishable  microfibrils  are present in many 
non-elastic  tissues such as the ocular zonule,  tendon, and 
bone where they may serve an anchoring  function (Fleisch- 
majer et al., 1991; Keene et al., 1991a,b). These microfibrils 
have a complex ultrastructure  with a diameter of 10-14 nm 
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and an average, but variable, beaded periodicity of 50-55 nm 
(Fleischmajer et al., 1991; Keene et al., 1991b; Kielty et al., 
1991, 1993a). 
The recent cloning and sequencing of fibrillin has revealed 
that this protein contains  a complex multi-domain  structure 
(Maslen et al.,  1991; Corson et al.,  1993;  Pereira et al., 
1993). The molecule comprises multiple epidermal growth 
factor  (EGF)-like motifs interspersed with  8-cysteine  re- 
peats with homology to the TGF-B1 binding protein and sev- 
erai apparently  unique cysteine-rich  motifs.  However,  the 
organization of fibrillin monomers within assembled micro- 
fibrils and the molecular interactions  involved in their poly- 
merization  are largely undefined. It has been suggested that 
fibrillin  monomers associate in a head-to-tail arrangement 
which may be stabilized by inter-molecular  disulphide bonds 
(Sakai et al., 1991). Furthermore, calcium-binding  by EGF- 
like domains may profoundly influence microfibril assembly 
by stabilizing conformations required for protein-protein in- 
teractions or by forming bridges between domains (Handford 
et al.,  1991). 
The Marfan syndrome has an autosomal dominant inheri- 
tance pattern with virtually complete penetrance,  but at the 
clinical level is characterized  by a strikingly  heterogeneous 
spectrum of inter-  and intra-familial  phenotypes (Godfrey, 
1993).  The complexity of this  disorder is reflected by the 
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(Dietz et al.,  1991, 1992a,b,  1993a,b; Kainulalnen et al., 
1991,  1992,  1993;  Lee et al.,  1991; Godfrey et al.,  1993; 
Hewitt et al., 1993). There are to date, however, no satisfac- 
tory molecular explanations for how distinct fibriMn muta- 
tions affect microfibril assembly and functionality. 
To gain insights into Marfan genotype:phenotype relation- 
ships, we have used a combined biochemical and ultrastruc- 
tural approach to investigate fibrillin expression and assem- 
bly in dermal fibroblasts from two unrelated Marfan patients 
with defined mutations. In one case, a T to A point mutation 
substitutes the first highly conserved aspartate for glutamate 
within the calcium-binding consensus sequence of an EGF- 
like motif (Kainulainen et al.,  1993).  This patient, from a 
moderately affected two generation family, has predominantly 
skeletal manifestations. In the other case, a deletion corre- 
sponding to an exon encoding an EGF-like motif  has occurred 
in one allele (Godfrey et al., 1993). This mutation occurs in 
a four-generation family with skeletal, cardiovascular, and 
ocular involvement. Correlation of microfibrillar abnormal- 
ities with these mutations has contributed insights into the 
molecular basis of the Marfan syndrome. 
Materials and Methods 
Materials 
Bacterial coilagenase (type IA), phenylmethanesulphonyl  fluoride (PMSF), 
N-ethylmaleimide  (NEM),  Tween  20,  and prestained molecular weight 
markers were obtained from Sigma Chemical Co.  (Poole,  Dorset, UK). 
CNBr-activated  Sepharose  CL-4B,  Scpharose  CL-2B,  protein A-Sepha- 
rose,  and molecular weight  markers were  supplied  by Pharmacia-LKB 
(Milton Keynes, Bucks,  UK). Tissue culture media and plastics were ob- 
tained from GIBCO BRL (Paisley, Scotland,  UK). The radioisotope [35S]- 
TranSlabel  was  obtained from ICN Biomedicals  Ltd.  (High Wycombe, 
Bucks, UK). Marfan dermal fibroblast cell lines established from skin biop- 
sies were used in these investigations. The ceil line NB was supplied by Dr. 
Anne H. Child (St George's Hospital  Medical School,  London, UK) and 
Dr. F. Michael Pope (MRC Clinical Research Centre, Northwick Park Hos- 
pital, London, UK), and the cell line GK by Dr. Maurice Godfrey (Hollister 
Research  Laboratories, Omaha, NE). 
Cells and Cell Culture 
Marfan and control dermal fibroblasts  were routinely maintained in Dul- 
becco's minimum essential medium supplemented with 10% foetal calf se- 
rum, penicillin (400 U/ml), streptomycin  (50 mg/ml), and glutamine (200 
mg/ml). Confluent calls were labeled for 18 h with [35S]TranSlabel in me- 
dium containing 0.5%  foetal calf serum. In some experiments,  cells were 
pulse labeled for 30 rain with 250 ~Ci label, then chased for 1, 2, 6, and 
24 h. Labeled medium was fractionated by addition of solid (NI-]4)2SO4  to 
30% saturation at 4°C in the presence of 5 mM NEM, 2 mM PMSF, and 
10 mM EI31"A. Cell layers were sequentially extracted in 0.05 M Tris/HC1, 
pH 7.4, containing 0.4 M NaCl, 0.005 M EDTA, and 1% (vol/vol) Nonidet 
P40 (NET buffer), and 0.05 M Tris/HC1, pH 7.4, containing 4.0 M guani- 
dine HCI (GuCI2). Extracts were clarified by centrifugation for 15 rain at 
7,500 g on a bench microfuge, and soluble supernatants retained for analysis. 
For microfibril extractions,  calls were maintained at post-confluence  for 
up to three weeks.  Ceil layers were washed in 0.05 M Tris/HC1, pH 7.4, 
contalnins 0.4 M NaCI, then incubated for 3 h at 20°C in 0.05 M Tris/HC1, 
pH 7.4, contalnins 0.4 M NaCI, 0.005 M CaCI2, 0.1 mg/ml bacterial col- 
lngenase (type 1A), 2 mM PMSF, and 5 mM NEM. Soluble extracts were 
clarified by centrifugalion for 15 min at 7,500 g on a bench microfuge before 
size fractionation by gel filtration chromatography. 
Size Fractionation of  FibriUin Solubilized 
from Cell Layer Extracts 
Metabolically labeled GK and NB cell layer GuC12 extracts from 2 and 6 h 
pulse-chase time points were chromatographed on an analytical  gel filtra- 
tion column (1.5 x  25 cm) of Sepharose CL-2B.  The column was equili- 
brated and eluted at room temperature with 0.05 M Tris/HCI,  pH 7.4, con- 
talning 4.0 M GuCI2. In each run, 60 x  1 ml fractions were collected.  The 
elution positions of newly synthesized,  metabolically labeled fibrillin were 
determined by immunoprecipitaling flbrillin from appropriately  pooled 
fractions. 
Postconfluent ceil layer extracts solubilized by bacterial collagenase di- 
gestion were chromatograpbed directly without concentration under non- 
reducing,  nondenaturing conditions on a Sepharose CL-2B column equili- 
brated and elnted at room temperature with 0.05 M  Tris/HC1,  pH 7.4, 
containing 0.4 M NaC1. High-M, material present in the excluded volume 
(Vo) was retained for ultrastructural analysis. 
Immunoprecipitation 
Immunoprecipitation was carried out in NET buffer as described by Kielty 
et al. (1990). Briefly, 30% (NH4)2SO4 precipitates of cell culture medium 
were taken up in 1 ml NET buffer. Ceil layers were sequentially  extracted 
with NET buffer and with 4.0 M GuCI2. Ceil layer GuCI2 extracts  were 
dialyzed  extensively  against 0.05 M Tris/HCl, pH 7.4, containing 0.4 M 
NaCI and 0.005 M EDTA, and 0.1% (vol/vol) Nonidet P40 was added before 
immunoprecipitation. 
In view of the similar electrophoretic  mobilities on SDS-PAGE of fibro- 
nectin and fibrillin, fibrouectin was removed before immunoprecipitation  of 
fibriMn by two sequential  incubations with 100 ~tl 1:1 (vollvol) solution of 
gelatin-Sepharose. Samples  were then incubated for 1 h at 20°C with a 
1:100 dilution of a polyclonal fibriilin antiserum (Shuttleworth ct al., 1992; 
Kielty and Shuttleworth,  1993a; Waggett ct al., 1993), before the addition 
of 60 ml of a 1:1 (vol/vol) solution of protein A-scpbarose in NET buffer. 
Electrophoresis 
Immunoprecipitates were separated by discontinuous SDS-PAGE on 6% 
gels (Laemmli, 1970) under non-reducing conditions, then analyzed by flu- 
orography.  Molecular weights were determined by reference both to pre- 
stained standards (fumarnse [56,000],  pyruvate kinase [65,000],  fructose- 
6-phosphate kinase [88,000], ~galactosidase [125,000], c~2 macroglobulin 
[190,000]) and unstained standards (bovine serum albumin [67,000], lactate 
dehydrogenase  [140,000],  catalese [232,000],  ferritin [440,000],  thyro- 
globulin [669,000]). 
Ultrastructural Analysis 
Void volume fractions of cell layer extracts were visualized for their micro- 
fibril content by rotary shadowing using a modification  of the mica sand- 
wich technique (Kielty et aL, 1993). Immunogold electron microscopy was 
carried out as described by Waggett et al. (1993). 
Results 
Two Marfan dermal fibroblast lines were used in these inves- 
tigations. N-B cells have a T to A point mutation within FBN1 
causing an aspartate to glutamate amino acid substitution 
(DI229E;  Pereira et al.,  1993) (Kainulainen et al.,  1993). 
GK ceils have an FBN1 aUele with exon 54 (Pereira et al., 
1993)  deleted; this exon encodes a  single EGF-like motif 
(Godfrey et al., 1993). 
Count Distribution of Newly Synthesized Fibriliin 
Metabolically labeled fibrillin was immunoprecipitated from 
medium and cell layer fractions after 18 h labeling. De novo 
fibrillin synthesis was expressed as total counts incorporated 
into fibriMn (Table I). The two lines synthesized  comparable 
levels of  fibrillin and in both cases the majority of  newly syn- 
thesized fibriilin was deposited within the cell layer. 
Pulse-Chase Labeling and SDS-PAGE Analysis 
of FibriUin lmmunoprecipitates 
The electrophoretic mobility and time-course of secretion of 
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by Dermal Fibroblasts  from Two Marfan Patients 
Cell  Total fibrillin 
line  Medium  Cell layers  counts 
cpm/1  x  106  cpm/l x  106 
cells  %  cells  % 
N-B  3781  37  6435  63  10216 
GK  1047  12  7678  88  8725 
Cells were labeled for 18 h with [aSS]eysteine. Fibrillin was immunoprecipi- 
tared from  30% (NI-L)2SO4  precipitates of cell eultm~ medium  and from  sequen- 
tial detergent (NET) and denaturing (GuC12)  cell layer  extracts. The amount  and 
distribution of  newly  synthesized  fibrillin in the different  cell cultures  was com- 
pared by determining the total immunoprecipitable  fibrillin counts in the medi- 
um and cell layer  extracts. The figures  ~etJxesent  a single  experiment, but similar 
results were obtained in duplicate labeling experiments. 
fibrillin  into the medium by NB and GK cells  was deter- 
mined in pulse-chase expe  "nments (Fig. 1). Metabolically la- 
beled fibrillin was immunoprecipitated  from medium after 
chase times of 30 rain,  1, 2, 6, and 24 h,  and analyzed on 
SDS-PAGE gels under non-reducing conditions. Under these 
conditions,  fibrillin  migrated  as  a  single  component (300 
kD) with  a  similar  eleetrophoretic  mobility  to that previ- 
ously demonstrated for a range of normal cells (Kielty and 
Shuttleworth, 1993a). In the case of  GK, a second higher rel- 
ative  molecular  mass  fibrHlin-immunoreactive  component 
(330 kD) was also present. 
Labeled fibrillin was first detected in the medium of both 
cell fines after 2 h chase and in abundance by 6 h (Fig.  1 A). 
In the case of  NB, there was evidence by 6 h for the formation 
of higher relative molecular mass disulphide-bonded inter- 
mediate assemblies and larger aggregates. Aggregation was 
also a feature of the fibrillin secreted by the line GK, since 
the majority of immunoreactive material  did not enter the 
gel. Further, a 330-kD fibriilin-immunoreaetive component 
present in GK medium was seen to accumulate over a 24-h 
period.  The time-course of secretion of this component ap- 
peared similar to fibrillin  but its subsequent fate was quite 
distinct,  and if it is being incorporated into aggregates this 
process must be occurring at a  much reduced rate. 
A more complex electrophoretic pattern was observed for 
fibrillin immunoprecipitated from cell layer GuCI2 extracts 
(Fig. 1 B). In the ease of  GK, a component of 330 kD, a dou- 
blet migrating around 300 kD and a lower relative molecular 
mass doublet  (270  kD)  were detected.  In contrast,  newly 
synthesised fibrillin in NB cell layer extracts was immuno- 
precipitated  as high relative molecular mass aggregates. 
Size Fractionation of Cell Layer Extracts 
Aggregation of newly synthesized fibrillin within the GuC12- 
soluble  cell  layer  compartments  of NB  was  also  demon- 
strated by size fractionation of metabolically labeled fibrillin 
(Fig. 2). There was a clear shift in the elution profile of la- 
beled fibrillin between 2 and 6 h indicating increasing molec- 
ular mass (Fig. 2 B). No comparable change in elution pat- 
tern was detected between 2 and 6 h in GK cell layer extracts. 
Figure L  Pulse-chase  metabolic  labeling  and  analysis  of newly  synthesized  fibrillin  by SDS-PAGE.  Cells  were pulse-labeled  with 
[3SS]TranSlabel for 30 min, then chased for 30 min, 1, 2, 6, and 24 h. Fibrillin  immunoprecipitates  from medium and cell layer fractions 
were analyzed by SDS-PAGE on 6% gels under non-reducing conditions,  and fluorography.  (A) Newly synthesized  fibrillin secreted into 
medium. Medium was fraetionated with (NI-I4)2SO,  to 30% saturation  in the presence of inhibitors  before immunoprecipitation of fibril- 
lin.  Secreted fibrillin  monomers (300 kD) and high relative  molecular mass fibrillin-immtmoreactive  material  which failed to enter the 
stacking gel were identified in the medium of  GK and NB cells from 2 h. In the ease of  N'B cells, an aggregate of  intermediate  electrophoretic 
mobility was also present (black dot). GK cells secreted  an additional  fibriilin-immunoreaetive  component (330 kD) which accumulated. 
in the medium and did not appear to aggregate over 24 h (large arrowhead). (B) Newly synthesized fibrillin present in ceil layers. Fibrillin 
was immunoprecipitated from GuCl2-extracted  ceil layers at 2 and 6 h. GK cell layer extracts  exhibited  a complex .pattean o~ fibrillin- 
immunoreactive bands,  with a 330-KD component, a doublet (300 KD), a lower relative  molecular mass doublet (270 kD) and another 
further band (55 kD). These components accumulated between 2 and 6 h, particularly the 330-kD band. Extracts  of NB cell layers from 
2 and 6 h of chase contained high relative  molecular mass aggregates  of fibrillin. 
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Figure  2.  Time  course  of 
aggregation of newly synthe- 
sized  fibrillin in  cell  layers. 
GuC12 cell layer extracts at 2 
and 6 h chase time points were 
size fractionated by gel filtra- 
tion  chromatography  on  an 
analytical  Sepharose  CL-2B 
column  (see  Materials  and 
Methods). The eluted volume 
was pooled into four fractions 
as  indicated  before  fibril- 
lin immunoprecipitation.  Total 
fibrillin  counts  immunopre- 
cipitated  from  pooled  frac- 
tions of  2 and 6 h extracts were 
determined.  (A) Chromatog- 
raphy profile of NB cell layer 
extract. The OD2s0 traces for 
GK cell  layer extracts  were 
similar. (B) Histograms show- 
ing total immunoprecipitated 
fibrillin counts in each pooled 
fraction at 2 h (open bars) and 
6 h (cross-hatched bars). 
Ultrastructural Analyses 
Examination by rotary shadowing electron microscopy of 
high relative molecular mass material solubilized from post- 
confluent bacterial collagenase-solubilized cell layers dem- 
onstrated the  presence of extensive and  abundant micro- 
fibrils in control and Nil cell layers (Fig. 3, A and B). The 
microfibrils elaborated by control fibroblasts were similar in 
morphology to those previously isolated from tissues (Kielty 
et al.,  1991,  1993a). In marked contrast to the control cul- 
tures, the microfibrils extracted from NB cell layers were 
clearly abnormal in the interbead domains which were dif- 
fuse and poorly defined. This structural variation was appar- 
ent in all fields. In the case of GK cell layer extracts, no mor- 
phologically identifiable periodic microfibrillar assemblies 
were demonstrable. 
The identity of the microfibrillar assemblies was confirmed 
using immunogold localization of fibrillin epitopes (Fig. 4). 
Microfibrils from control cultures and those elaborated by 
NB cells were recognized by anti-fibrillin serum. The Nil 
microfibrils were markedly irregular in outline in compari- 
son to those elaborated by normal cells (Fig. 4, A and B). 
Fibrillin-immunoreactive material was also detected in GK 
cell layer extracts (Fig. 4  C). 
Discussion 
After the recent cloning and sequencing of the fibrillin gene 
FBN1 and its linkage to the Marfan syndrome, interest has 
focussed on documenting fibrillin mutations as a first step to 
defining genotype: phenotype relationships (Lee et al., 1991; 
Dietz et al., 1991,  1992a,b, 1993a,b; Godfrey et al., 1993; 
Hewitt et al.,  1993; Kainulainen et al.,  1991,  1992, 1993). 
Concurrently, efforts have been made to use biochemical as- 
says to identify fibrillin defects manifest at the level of fibril- 
lin synthesis, secretion, or deposition (McGookey-Milewicz 
et al., 1992; Raghunath et al., 1993). These methodologies, 
however, fail to address the central question concerning the 
structural and functional consequences of  defined mutations, 
and as a consequence, the aetiology of Marfan syndrome and 
the molecular basis of the clinical heterogeneity characteris- 
tic of this disorder have to date eluded molecular definition. 
It is clear that characterization of microfibrillar abnormali- 
ties reflecting distinct mutations is essential in order to arrive 
at a  comprehensive molecular explanation of the complex 
Marfan phenotype. The isolation of intact microfibrils from 
dermal fibroblast cultures has for the first time allowed direct 
correlation of biochemical defects and microfibrillar abnor- 
malities with defined fibrillin mutations. 
Examination by rotary shadowing electron microscopy of 
high relative molecular mass fractions material isolated from 
Marfan cell layers clearly showed that NB cells were capable 
of assembling abundant and extensive periodic microfibrils. 
However, the appearance of these microfibrils was abnormal 
with  diffuse, poorly defined interbead domains,  in  sharp 
contrast to the structural organization apparent in micro- 
fibrils elaborated by normal fibroblasts. In even greater con- 
trast, no morphologically identifiable microfibrils at all could 
be seen in GK cell layer extracts, although high molecular 
mass  fibrillin assemblies  were detected immunologically. 
These observations suggest that in both Marfan cell lines 
products of mutated alleles are secreted and become incor- 
porated into fibrillin assemblies. This is the first direct visual 
evidence for abnormalities in fibrillin aggregation and in mi- 
crofibrillar characteristics of Marfan patient cells. Studies 
have been described where attempts were made to classify 
Marfan cell lines in terms of defects in fibrillin secretion and 
deposition (McGookey-Milewitz et al.,  1992). Those stud- 
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graphs after rotary shadowing 
of fibrillin-containing  micro- 
fibrils isolated from postcon- 
fluent cell layers. Microfibrils 
were  isolated  from postcon- 
fluent  cell  layers  of  normal 
fibroblasts (.4) and fibroblasts 
from patient Nil (B). Fibrillin 
assemblies  were  clearly rec- 
ognized  by  their  distinctive 
beaded  appearance.  Micro- 
fibrils  elaborated  by  the 
patient  cells  were  morpho- 
logically  distinct  from those 
isolated from normal cultures, 
with ill-defined, diffuse inter- 
bead regions. The mierofibrils 
shown were representative of 
all  the  fields  examined  for 
both cell types. Bars, 250 nm. 
ies addressed the question of processing but not the aggrega- 
tion of fibrillin. Here, we describe two Marfan dermal fibro- 
blast lines for which the time-course of fibrillin secretion was 
similar to that previously described for a  range of normal 
cells (Kielty and Shuttleworth,  1993a), but which exhibited 
differences with respect both to formation of aggregates in 
medium and cell layers and elaboration of a fibriUin-rich ma- 
trix. Some of these differences were manifest in the electro- 
phoretic pattern of newly synthesized fibrillin secreted by the 
two lines.  The major fibrillin band immunoprecipitated in 
both cases had a similar electrophoretic mobility (300 kD), 
which is surprising in view of the fact that the mutated FBN1 
allele of GK encodes a polypeptide lacking 43 amino acids 
(Godfrey et al.,  1993), but probably reflects the difficulties 
in  resolving  such  large  proteins  electrophoretically.  The 
identity of the 330-kD fibrillin-immunoreactive component 
secreted by GK cells is unclear and was not previously de- 
tected  in  fibriUin  immunoprecipitates  from  normal  cells 
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assemblies treated with anti-fibriUin serum and second antibody- 
immunogold conjugate. Immunogold localization of fibrillin epi- 
topes present on fibriUin assemblies isolated from normal fibro- 
blasts (A), fibroblasts from patient NB (B), and fibroblasts from 
patient GK (C) confirmed the identity of the rnicmfibrillar assem- 
blies elaborated by normal and NB ceils. The NB microfibrils were 
(Kielty and Shuttleworth, 1993a), although a component of 
similar size has been described in fibrillin immunoprecipi- 
tates from cell lysates (McGookey-Milewicz et al.,  1992). 
If the component represents the product of a mutated allele, 
it is unclear whether it cannot be incorporated into micro- 
fibrils or whether it can be incorporated but at a much reduced 
rate. The failure to detect normal microfibrils however, im- 
plicates the product of  the mutated allele in fibrillin polymer- 
ization. The presence of the 330-kD component might imply 
a processing defect although there is no consensus on the oc- 
currence of fibrillin processing or its role in microfibril as- 
sembly. The existence of a precursor form of fibrillin has, 
however, been suggested from immunoprecipitation experi- 
ments where both fibrillin and "profibrillin"  molecules larger 
than fibrillin by ,x,30,000 were identified (McGookey-Mile- 
wicz et al.,  1993). In the case of NB, fibrillin aggregation 
to high relative molecular mass assemblies followed a simi- 
lar  pattern  to  that  previously observed  for normal  cells 
(Kielty and Shuttleworth, 1993a), and this was reflected in 
their capacity to make microfibrils. 
It is established that fibrillin is the major structural ele- 
ment of this class of connective tissue microfibrils (Sakai et 
al., 1986, 1991). However, it has recently been demonstrated 
that fibrillin exists as a family of  isoforms encoded by distinct 
structural  genes  and  a  plethora of candidate microfibril- 
associated molecules including microfibril-associated glyco- 
protein (MAGP) have also been described (Gibson et al., 
1991). The precise molecular composition of  the microfibrils 
and their mechanism of assembly remain to be resolved. It 
is clear, however, from the present study that defective fibril- 
lin encoded by the FBN1 locus has considerable influence on 
microfibrillar stability. 
The exon deletion that occurs in GK is one of several dele- 
tion mutations that have been described in Marfan patients 
(Kainulainen et al.,  1992,  1993; Dietz et al.,  1993a; God- 
frey et al., 1993). These deletions reflect distinct mutations 
within the FBN1 gene. In one case, a genomic deletion span- 
ning three EGF-like motifs has occurred (Kainulainen et al., 
1992). An unusual exon-skipping mutation caused by a pre- 
mature termination has also been described (Dietz et al., 
1993a). Two examples of  intronic mutations causing splicing 
defects and resulting in both cases in the skipping of an exon 
encoding an entire EGF-like domain,  have been reported 
(Godfrey et al., 1993; Kainulalnen ct al., 1993). In the case 
of patient GK, the single exon deletion arises as a  conse- 
quence  of a  donor  splice  site  mutation  (Godfrey et  al., 
1993). It remains to be seen whether the mechanism or posi- 
tion of  the splice variants reflects the severity of  the condition. 
At a clinical level, the proband GK has major cardiovascu- 
lar, skeletal, and ocular symptoms. The skeletal manifesta- 
tions  include  excessive height,  arachnodactyly,  scoliosis, 
pectus  excavatum,  marked joint  instability,  and  dolicho- 
stenomelia. In addition, echcardiography has revealed mitral 
valve prolapse and regurgitation and a  dilated aortic root, 
and the patient also suffers from ectopia lentis and severe 
myopia (Godfrey et al., 1993). One explanation for the corn- 
markedly irregular in outline in comparison to those elaborated by 
normal cells. Fibrillin-immunoreactive aggregates, but no micro- 
fibrils, were detected in GK cell layer extracts. Bars, 250 nm. 
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cultures is that shortened products of the mutated allele can- 
not align correctly to form the intermolecular interactions 
required to ensure microfibriilar integrity.  In contrast,  the 
patient NB is an affected member of a two-generation family 
with predominantly skeletal manifestations. The phenotype 
includes excessive height, kyphoscoliosis, hypermobile joints 
which dislocate, aortic dilatation, stretchy skin, easy bruis- 
ability,  umbilical hernia, prematurity,  and duodenal ulcer, 
but a lack of all ocular symptoms (Kainulainen  et al., 1993). 
The single base change described for NB is one of a number 
of examples of point mutations in FBN1  that are linked to 
Marfan  syndrome  (Dietz  et  al.,  1991,  1992a,b, 1993b; 
Kainulainen  et al., 1993). In this case, the aspartate to gluta- 
mate  amino  acid  substitution  within the  calcium-binding 
consensus sequence of an EGF-like domain is predicted to 
disrupt calcium-binding and monomer conformation (Kielty 
and Shuttleworth,  1993b). Our identification of abnormal 
microfibrils elaborated by NB cells supports this notion and 
suggests that the mutation itself may be located within the 
interbead domain. A fascinating feature of the extensive mi- 
crofibrils elaborated by NB  cells is that despite their dis- 
rupted  organization,  the  periodicity  remains  remarkably 
constant. 
Despite the number of mutations that have been reported, 
and the relationship that has been established between FBN1 
and Marfan syndrome, no comprehensive molecular expla- 
nation  of microfibril  structure  and  function  arising  from 
these data has been derived to date.  The approach outlined 
in this  study  provides  a means to test structure:  function 
predictions and how individual mutations give rise to the 
heterogeneous clinical manifestations of Marfan syndrome. 
We have described microfibriUar abnormalities characteris- 
tic of two patient  cell lines which reflect the structural  and 
functional disruptions that manifest in these patients  as dis- 
tinct clinical phenotypes. It is anticipated  that further similar 
analyses of further patient lines with defined mutations will 
provide major insights into genotype:  phenotype  relation- 
ships of Marfan syndrome. The correlation of microfibrillar 
abnormalities with defined fibrillin mutations will also un- 
doubtedly shed light on the complex process of microfibril 
assembly. 
This work was supported by the Medical Research Council and Wellcome 
Trust. 
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